3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroendocrine Tumors
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioblastoma
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Interventions
enzalutamide
28
Magnetic Resonance Spectroscopy
28
Specimen Handling
21
apalutamide
18
Androgen Antagonists
16
Abiraterone Acetate
15
Prednisone
14
Radiosurgery
13
abiraterone
12
Docetaxel
12
Radiotherapy
11
Biopsy
10
darolutamide
9
Nivolumab
8
Radiation
7
Pluvicto
7
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
7
niraparib
6
luprolide acetate gel depot
6
cabazitaxel
6
Surveys and Questionnaires
6
gallium 68 PSMA-11
5
bicalutamide
5
Radiotherapy, Intensity-Modulated
5
Lutetium-177
5
Leuprolide
5
Gonadotropin-Releasing Hormone
5
radium Ra 223 dichloride
4
pembrolizumab
4
olaparib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
pazopanib
×
30 days
×
Clear all
No trials found.